BSH 2024 | Addressing the increased risk of cardiovascular disease in patients with MPNs
Arjun Ghosh
• 25 Apr 2024
Arjun Ghosh, MBBS, MSc, PhD, FHEA, FACC, FESC, FRCP, FICOS, University College London Hospitals, London, UK, briefly comments on the increased risk of thrombosis and cardiovascular (CV) events in patients with myeloproliferative neoplasms (MPNs). Dr Ghosh highlights a study that aimed to modify traditional risk-scoring algorithms to consider disease-specific factors and avoid underestimating CV risk in patients. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
